TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations

about

TERT promoter wild-type glioblastomas show distinct clinical features and frequent PI3K pathway mutations

Item

http://www.wikidata.org/entity/Q58604367

description

article

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@en

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@nl

type

Item

label

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@en

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@nl

prefLabel

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@en

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@nl

P1476

TERT promoter wild-type gliobl ...... requent PI3K pathway mutations

@en

P2093

A John Iafrate

http://www.w3.org/2001/XMLSchema#string

Daniel P Cahill

http://www.w3.org/2001/XMLSchema#string

Julie J Miller

http://www.w3.org/2001/XMLSchema#string

Shilpa S Tummala

http://www.w3.org/2001/XMLSchema#string

Tareq A Juratli

http://www.w3.org/2001/XMLSchema#string

Tristan Penson

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas

Loss of ARID1A expression sensitizes cancer cells to PI3K- and AKT-inhibition

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.

Coexistent ARID1A-PIK3CA mutations promote ovarian clear-cell tumorigenesis through pro-tumorigenic inflammatory cytokine signalling.

Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors

Epithelioid GBMs show a high percentage of BRAF V600E mutation.

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas.

P2888

s40478-018-0613-2

P304

106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-018-0613-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Erik Williams

P577

2018-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107682077

http://www.w3.org/2001/XMLSchema#string

P698

30333046

http://www.w3.org/2001/XMLSchema#string

P932

6193287

http://www.w3.org/2001/XMLSchema#string